Search results
Showing 226 to 240 of 243 results for maternity
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)
Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.
Interim methods guide for developing good practice guidance (PMG15)
This interim methods guide is based on the general principles and methods included in other methods guides for developing NICE guidance
Methods for the development of NICE public health guidance (third edition) (PMG4)
This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance
This manual explains how NICE develops and updates social care guidance. It provides advice on the technical aspects of guidance development and the methods used
This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE
Our centralised approach to prioritising guidance topics ensures that we produce guidance that is relevant, timely, accessible, and has demonstrable impact.
Smoking cessation positively impacts all 5 clinical areas identified by Core20PLUS5 adults.
Ensure annual physical health checks for people with severe mental illness to at least nationally set targets.
A clear focus on Chronic Obstructive Pulmonary Disease (COPD) driving up uptake of Covid, Flu and Pneumonia vaccines to reduce infective exacerbations and emergency hospital admissions due to those exacerbations.
Hypertension case finding and optimal management and lipid optimal management
Hypertension case finding and optimal management and lipid optimal management Maternity Respiratory Severe mental illness Smoking...
Early Cancer Diagnosis: 75% of cases diagnosed at stage 1 or 2 by 2028.
Ensuring continuity of care for women from Black, Asian and minority ethnic communities and from the most deprived groups.
We've mapped relevant NICE guidance and advice to NHS England’s Core20PLUS5 for adults
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Our staff really enjoy working with us, thanks to our great package of rewards and benefits.